ArticleGastrointestinal cancer research : GCR2009
Principles of modern radiation techniques for esophageal and gastroesophageal junction cancers.
Article in Gastrointestinal cancer research : GCR, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 16 citations in OpenAlex.
- Assessment of Field-in-Field, 3-Field, and 4-Field Treatment Planning Methods for Radiotherapy of Gastro-Esophageal Junction Cancer.Journal of biomedical physics & engineering · 2022Article
- Article
- Reduced lung dose during radiotherapy for thoracic esophageal carcinoma: VMAT combined with active breathing control for moderate DIBH.Radiation oncology (London, England) · 2013Article
- Technological advances in radiotherapy for esophageal cancer.World journal of gastroenterology · 2010Review
- Is dose escalation achievable for esophageal carcinoma?Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation OncologyArticle
- Characterization of Respiration-Induced Motion in Prone Versus Supine Patient Positioning for Thoracic Radiation Therapy.Advances in radiation oncologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Esophageal cancer is a highly virulent neoplasm with high morbidity and mortality. With the benefit of radiotherapy (RT) combined with chemotherapy clearly established, the challenge is in the accurate and safe delivery of radiotherapy. Improved understanding of patterns of esophageal cancer relapse and tumor spread and of organ motion in the upper thorax and abdomen have allowed for implementation of more conformal radiation techniques, including respiratory-gated RT, imageguided RT (IGRT), and intensity-modulated RT (IMRT). At a minimum, successful implementation of conformal radiation delivery requires a detailed understanding of esophageal anatomy and radiobiological principles, an individualized assessment of organ motion, precise patient immobilization techniques, and adequate physics and dosimetry expertise. To aid the practicing clinician, the National Comprehensive Cancer Network (NCCN) has recently incorporated detailed recommendations on simulation, treatment planning, target volumes, and dose limits for select critical normal structures. The practicing clinician is urged to utilize the multitude of resources now available to ensure that optimal adjuvant radiotherapy for esophageal cancer is delivered safely and accurately.
Identifiers
19461922PMC2684733W159258223What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.